Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study
尼达尼布治疗难治性转移性结直肠癌患者(LUME-Colon 1):一项 III 期、国际性、随机、安慰剂对照研究
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdy241
Van Cutsem, E; Yoshino, T; Lenz, H J; Lonardi, S; Falcone, A; Limón, M L; Saunders, M; Sobrero, A; Park, Y S; Ferreiro, R; Hong, Y S; Tomasek, J; Taniguchi, H; Ciardiello, F; Stoehr, J; Oum'Hamed, Z; Vlassak, S; Studeny, M; Argiles, G